View Item 

Show simple item record

Detection of Mutated K- ras DNA in Urine, Plasma, and Serum of Patients with Colorectal Carcinoma or Adenomatous Polyps

dc.contributor.authorSu, Ying-Hsiuen_US
dc.contributor.authorWang, Mengjunen_US
dc.contributor.authorBrenner, Dean E.en_US
dc.contributor.authorNorton, Pamela A.en_US
dc.contributor.authorBlock, Timothy M.en_US
dc.date.accessioned2010-06-01T19:05:23Z
dc.date.available2010-06-01T19:05:23Z
dc.date.issued2008-08en_US
dc.identifier.citationSu, Ying-Hsiu; Wang, Mengjun; Brenner, Dean E.; Norton, Pamela A.; Block, Timothy M. (2008). "Detection of Mutated K- ras DNA in Urine, Plasma, and Serum of Patients with Colorectal Carcinoma or Adenomatous Polyps." Annals of the New York Academy of Sciences 1137(1 Circulating Nucleic Acids in Plasma and Serum V ): 197-206. <http://hdl.handle.net/2027.42/72277>en_US
dc.identifier.issn0077-8923en_US
dc.identifier.issn1749-6632en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72277
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18837947&dopt=citationen_US
dc.format.extent151088 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Incen_US
dc.rights© 2008 New York Academy of Sciencesen_US
dc.subject.otherUrine DNAen_US
dc.subject.otherCirculating DNAen_US
dc.subject.otherCancer Biomarkersen_US
dc.subject.otherK -Ras Mutationsen_US
dc.subject.otherCancer Detectionen_US
dc.titleDetection of Mutated K- ras DNA in Urine, Plasma, and Serum of Patients with Colorectal Carcinoma or Adenomatous Polypsen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelScience (General)en_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartments of Internal Medicine and Pharmacology, 2150B Cancer and Geriatrics Center, University of Michigan Medical Center, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationotherDepartment of Microbiology and Immunology, College of Medicine, Drexel University, Doylestown, Pennsylvania, USAen_US
dc.identifier.pmid18837947en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72277/1/annals.1448.027.pdf
dc.identifier.doi10.1196/annals.1448.027en_US
dc.identifier.sourceAnnals of the New York Academy of Sciencesen_US
dc.identifier.citedreferenceUtting, M. et al. 2002. Microsatellite analysis of free tumor DNA in urine, serum, and plasma of patients: a minimally invasive method for the detection of bladder cancer. Clin. Cancer Res. 8: 35 – 40.en_US
dc.identifier.citedreferenceHoque, M.O. et al. 2003. High-throughput molecular analysis of urine sediment for the detection of bladder cancer by high-density single-nucleotide polymorphism array. Cancer Res. 63: 5723 – 5726.en_US
dc.identifier.citedreferenceCairns, P. 2004. Detection of promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients. Ann. N.Y. Acad. Sci. 1022: 40 – 43.en_US
dc.identifier.citedreferenceDulaimi, E. et al. 2004. Promoter hypermethylation profile of kidney cancer. Clin. Cancer Res. 10: 3972 – 3979.en_US
dc.identifier.citedreferenceDulaimi, E. et al. 2004. Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel. Clin. Cancer Res. 10: 1887 – 1893.en_US
dc.identifier.citedreferenceCairns, P. et al. 2001. Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. Clin. Cancer Res. 7: 2727 – 2730.en_US
dc.identifier.citedreferencePapadopoulou, E. et al. 2004. Cell-free DNA and RNA in plasma as a new molecular marker for prostate cancer. Oncol. Res. 14: 439 – 445.en_US
dc.identifier.citedreferenceSu, Y.H. et al. 2004. Human urine contains small, 150 to 250 nucleotide-sized, soluble DNA derived from the circulation and may be useful in the detection of colorectal cancer. J. Mol. Diagn. 6: 101 – 107.en_US
dc.identifier.citedreferenceBotezatu, I. et al. 2000. Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism. Clin. Chem. 46: 1078 – 1084.en_US
dc.identifier.citedreferenceSerdyuk, O.I. et al. 2001. Detection of mutant k-ras sequences in the urine of cancer patients. Bull. Exp. Biol. Med. 131: 283 – 284.en_US
dc.identifier.citedreferenceTaback, B. & Hoon, D.S.B. 2004. Circulating nucleic acids and proteomics of plasma/serum: clinical utility. Ann. N.Y. Acad. Sci. 1022: 1 – 8.en_US
dc.identifier.citedreferenceChan, A.K.C. et al. 2003. Cell-free nucleic acids in plasma, serum and urine: a new tool in molecular diagnosis. Ann. Clin. Biochem. 40: 122 – 130.en_US
dc.identifier.citedreferenceLo, Y.M. et al. 1997. Presence of fetal DNA in maternal plasma and serum. Lancet 350: 485 – 487.en_US
dc.identifier.citedreferenceNawroz, H. et al. 1996. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat. Med. 2: 1035 – 1037.en_US
dc.identifier.citedreferenceChen, X.Q. et al. 1996. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat. Med. 2: 1033 – 1035.en_US
dc.identifier.citedreferenceGoessl, C. et al. 1998. Microsatellite analysis of plasma DNA from patients with clear renal carcinoma. Cancer Res. 58: 4728 – 4732.en_US
dc.identifier.citedreferenceWong, I.H.N. et al. 1999. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res. 59: 71 – 73.en_US
dc.identifier.citedreferenceEsteller, M. et al. 1999. Detection of abbertant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res. 59: 67 – 70.en_US
dc.identifier.citedreferencePathak, A.K. et al. 2006. Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool. Clin. Chem. 52: 1833 – 1842.en_US
dc.identifier.citedreferenceShapiro, B. et al. 1983. Determination of circulating DNA Levels in patients with benign of malignant gastrointestinal disease. Cancer 51: 2116 – 2120.en_US
dc.identifier.citedreferenceMaltzman, T. et al. 2001. Ki- ras proto-oncogene mutations in sporadic colorectal adenomas: relationship to histologic and clinical characteristics. Gastroenterology 121: 302 – 309.en_US
dc.identifier.citedreferenceAhlquist D.A. et al. 2000. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 119: 1219 – 1227.en_US
dc.identifier.citedreferenceRashid, A. et al. 2002. K- ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: a population-based study in China. Clin. Cancer Res. 8: 3156 – 3163.en_US
dc.identifier.citedreferenceVogelstein, B. et al. 1998. Genetic alterations during colorectal-tumor development. New Engl. J. Med. 319: 525 – 532.en_US
dc.identifier.citedreferenceAndersen, S. et al. 1999. Villous, hypermucinous mucosa in long standing ulcerative colitis shows high frequency of K- ras mutations. Gut 45: 686 – 692.en_US
dc.identifier.citedreferenceOtori, K. et al. 1997. High frequency of K-ras mutations in human colorectal hyperplastic polyps. Gut 40: 660 – 663.en_US
dc.identifier.citedreferenceTakayama, T. et al. 2001. Analysis of K- ras, APC, and B- catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis. Gastroenterology 121: 599 – 611.en_US
dc.identifier.citedreferencePrzybojewska, B. et al. 2000. H-RAS, K-RAS, and N-RAS gene activation in human bladder cancers. Cancer Genet. Cytogenet. 121: 73 – 77.en_US
dc.identifier.citedreferenceSu, Y.H. et al. 2004. Transrenal DNA as a diagnostic tool: important technical notes. Ann. N.Y. Acad. Sci. 1022: 81 – 89.en_US
dc.identifier.citedreferenceWang, M. et al. 2004. Preferential isolation of fragmented DNA enhances the detection of circulating mutated k-ras DNA. Clin. Chem. 50: 211 – 213.en_US
dc.identifier.citedreferenceChan, K.C.A. et al. 2003. Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients. Cancer Res. 63: 2028 – 2032.en_US
dc.identifier.citedreferenceTaback, B. et al. 2004. Quantification of circulating DNA in the plasma and serum of cancer patients. Ann. N.Y. Acad. Sci. 1022: 17 – 24.en_US
dc.identifier.citedreferenceJorg, H.H. et al. 2004. Patterns of circulating hepatitis B virus serum nucleic acids during lamivudine therapy. Ann. N.Y. Acad. Sci. 1022: 271 – 281.en_US
dc.identifier.citedreferenceKoffler, D. et al. 2006. The occurrence of single-stranded DNA in the serum of patients with systemic lupus erythematosus and other diseases. J. Clin. Invest. 52: 198 – 204.en_US
dc.identifier.citedreferenceLeon, S.A. et al. 1997. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 37: 646 – 650.en_US
dc.identifier.citedreferenceSteinman, C.R. 1982. Circulating DNA in polyarteritis nodosa and related syndromes. Arthritis Rheum. 25: 1425 – 1430.en_US
dc.identifier.citedreferenceSteinman, C.R. 1984. Circulating DNA in systemic lupus erthematosus. J. Clin. Invest. 73: 832 – 841.en_US
dc.identifier.citedreferenceNeurath, A.R. et al. 1994. Strategies for detection of transfusion-transmitted viruses eluding identification by conventional serologic tests II. Detection of host DNA in human plasmas with elevated alanine aminotransferase. J. Virol. Methods 8: 73 – 86.en_US
dc.identifier.citedreferenceJahr, S. et al. 2001. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 61: 1659 – 1665.en_US
dc.identifier.citedreferenceAnker, P. et al. 1999. Detection of circulating tumor DNA in the blood (plasma/serum) of cancer patients. Cancer Metast. Rev. 18: 65 – 73.en_US
dc.identifier.citedreferenceArai, N. et al. 1999. Enhanced epithelial cell turnover associated with p53 accumulation and high p21WAF1/CIP1 expression in ulcerative colitis. Modern Pathol. 12: 604 – 611.en_US
dc.identifier.citedreferenceNakamura, T. et al. 1995. Cell death in colorectal polyps as evaluated by in situ 3′-tailinig reaction and its relationship to BCL-2 expression. Pathol. Int. 45: 721 – 728.en_US
dc.identifier.citedreferenceSchulte-Hermann, R. et al. 1995. Role of active cell death (apoptosis) in multi-stage carcinogenesis. Toxicol. Lett. 82/83: 143 – 148.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
annals.1448.027.pdf
Size:
147.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.